{"nct_id":"NCT06152575","title":"MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-02-08","start_date_type":"ACTUAL","primary_completion_date":"2026-08-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-12-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PFE"]}